The effects of tildrakizumab in the epigenetic aging deviation of psoriasis: A 52-week open-label study

More on DunedinPACE

• Blood methylation clocks capture two distinct biological domains of aging

  Genes · 3 Oct 2026

• Diet benefits for epigenetic aging may reflect familial factors

  GeroScience · 3 Oct 2026

• Accelerated epigenetic aging predicts major depression and brain changes after trauma

  medRxiv · 2 Oct 2026

• Epigenetic age links to higher dementia risk in older adults

  Neurology Open Access · 4 Oct 2026